𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Botulinum toxin treatment for blepharospasm associated with myasthenia gravis

✍ Scribed by Kenju Hara; Akiko Matsuda; Yuko Kitsukawa; Keiko Tanaka; Masatoyo Nishizawa; Asako Tagawa

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
113 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Botulinum toxin A injections improve apr
Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
✍ Masato Kanazawa; Takayoshi Shimohata; Masahisa Sato; Osamu Onodera; Keiko Tanaka πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 44 KB

Botulinum Toxin A Injections Improve Apraxia of Eyelid Opening without Overt Blepharospasm Associated with Neurodegenerative Diseases Apraxia of eyelid opening (AEO) designates an intermittent inability to open the eyes voluntarily. 1 AEO is observed in patients with neurodegenerative diseases, incl

Botulinum toxin A injections improve apr
Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
✍ Eva Lopez Valdes; Ignacio Javier Posada Rodriguez; Rafael Bilbao-Calabuig πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 34 KB

We have read with interest the letter of Kanazawa 1 about improvement of apraxia of eyelid opening (AEO) with botulinum toxin A. The term AEO defined as an intermittent inability to open the eyes voluntarily is not a specific entity; it is only a clinical sign whose physiopathological origin is var

Reply: Botulinum toxin A injections impr
Reply: Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
✍ Masato Kanazawa; Takayoshi Shimohata; Masatoyo Nishizawa πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 34 KB

We have read with interest the letter of Kanazawa 1 about improvement of apraxia of eyelid opening (AEO) with botulinum toxin A. The term AEO defined as an intermittent inability to open the eyes voluntarily is not a specific entity; it is only a clinical sign whose physiopathological origin is var